On the 2nd of January 2015, the Azienda Ospedaliera di Padova (AOSP) has enrolled its first patient in the DEEP-2 study (multicentre, randomized, open label, controlled trial aimed at comparing the efficacy of deferiprone and deferasirox in paediatric patients). Other two paediatric patients have been included in […]
The DEEP project has received research funding from the European Union under the 7th Framework Programme
News | DEEP Project - Part 12
Paediatric-targeted treatments – Article on International Innovation
Iron chelation associated to blood transfusions is required for the successful treatment of many haemoglobinopathies but, as yet, few drugs have been developed for children. A consortium of experts in the DEEP network is thus conducting paediatric clinical trials on an international scale to confi rm the suitability […]
DEEP featured on research*eu results
The European Commission featured the DEEP Project in Issue #34 of the research*eu results magazine. With Prof. Ceci answering the editorial staff’s questions, the article focuses on the achievements of the project studies in the past three years, which led to a new formulation of deferiprone with a better taste suitable for children, as well as valuable data on the correct dosage to be administered for each age group.
Children have the right to know
An article by the title “That’s Health, Folks!” appeared on January 10th, 2014 on HorizonHealth.eu, focussing on the importance of children’s right to be informed on what will happen to them when they participate in a clinical trial.
The article includes an interview to Prof […]